EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Development and exacerbation of autoimmune hemolytic anemia following COVID ‐19 vaccination: A systematic review

Abdollah Jafarzadeh iD, Sara Jafarzadeh, Mohammad Pardehshenas, Maryam Nemati, Seyed Mohammad Javad Mortazavi

International Journal of Laboratory Hematology · 2023-04 · 45 (2) · 145-155

DOI: 10.1111/ijlh.13978 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 08.10.2022. Verfasst von Abdollah Jafarzadeh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran. Hauptthemen laut MEDLINE: Anemia, Hemolytic, Autoimmune, COVID-19. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune hemolytic anemia (AIHA) is caused by the production of autoantibodies against RBCs. COVID‐19 vaccines can reduce the risk of severe disease, however, various adverse effects such as AIHA were observed following vaccination. This review aimed to assess the relationship of AIHA and COVID‐19 vaccination using the PRISMA guidelines. Among 18 cases included in this review, new post‐vaccination AIHA development was reported in 11 patients (7 women and 4 men) with a median age of 67.0 years. In 7 of 11 and 3 of 11 cases, the onset of symptoms occurred after first and second vaccine dose with median times of 7 and 14 days, respectively. In 1 of 11 cases, the AIHA occurred on Day 17 after booster vaccination. Ten of 11 and 1 of 11 AIHA patients received mRNA‐ and vector‐based vaccine, respectively. After vaccination, 9 of 11, 1 of 11, and 1 of 11 AIHA patients developed warm IgG, cold IgM, and mixed autoantibodies against RBCs, respectively. Significant AIHA exacerbation was reported in seven patients (four women and three men) with a median age of 73.0 years. In 4 of 7 and 2 of 7 exacerbated AIHA cases, the onset of symptoms occurred after first and second vaccine dose with median times of 7 and 3 days, respectively. In 1 of 7 exacerbated AIHA cases, the onset of symptoms was observed on Day 2 after booster vaccination. All exacerbated AIHA cases received mRNA‐based vaccines; 3 of 7 and 4 of 7 exacerbated AIHA cases developed IgG and IgM against RBCs, respectively. This review provides a comprehensive explanation regarding the AIHA development and exacerbation after COVID‐19 vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Hemolytic, AutoimmuneCOVID-19AgedFemaleHumansMaleAutoantibodiesCOVID-19 VaccinesImmunoglobulin GImmunoglobulin MVaccination

Stichwörter der Autor:innen

COVID-19SARS-CoV-2autoimmune hemolytic anemiavaccination

Substanzen

AutoantibodiesCOVID-19 VaccinesImmunoglobulin GImmunoglobulin M

Autor:innen und Institutionen

  • Department of Immunology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
  • Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
  • Department of Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
  • Student Research Committee, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
  • Department of Microbiology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
  • Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

ORCID-Profile: Abdollah Jafarzadeh

Zitieren

APA

Jafarzadeh, A., Jafarzadeh, S., Pardehshenas, M., Nemati, M., & Mortazavi, S. M. J. (2023). Development and exacerbation of autoimmune hemolytic anemia following COVID ‐19 vaccination: A systematic review. International Journal of Laboratory Hematology, 45(2), 145-155. https://doi.org/10.1111/ijlh.13978

Vancouver

Jafarzadeh A, Jafarzadeh S, Pardehshenas M, Nemati M, Mortazavi SMJ. Development and exacerbation of autoimmune hemolytic anemia following COVID ‐19 vaccination: A systematic review. International Journal of Laboratory Hematology. 2023;45(2):145-155. doi:10.1111/ijlh.13978

BibTeX
@article{Jafarzadeh2023,
  author = {Jafarzadeh, Abdollah and Jafarzadeh, Sara and Pardehshenas, Mohammad and Nemati, Maryam and Mortazavi, Seyed Mohammad Javad},
  title = {Development and exacerbation of autoimmune hemolytic anemia following COVID ‐19 vaccination: A systematic review},
  journal = {International Journal of Laboratory Hematology},
  year = {2023},
  volume = {45},
  number = {2},
  pages = {145--155},
  doi = {10.1111/ijlh.13978}
}
Kostenlos starten →